Ocugen, Inc. (OCGN) vs Vogenx Inc (VOGX)

Ocugen, Inc. and Vogenx Inc are both Biotechnology companies. Ocugen, Inc. and Vogenx Inc are of similar size ($276.9M and $270.8M). Across the 3 metrics below, Ocugen, Inc. leads on 2 and Vogenx Inc on 1.

Valuation

Metric OCGN VOGX Biotechnology median
P/E n/m — 10.60
P/S 66.01 n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 48.75 n/m 9.02
Earnings yield (21.57%) — (32.88%)
Free cash flow yield (20.26%) 0.00% (23.13%)

Profitability

Metric OCGN VOGX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (1,444.47%) — 0.00%
Net margin (1,367.61%) — 0.00%
Free cash flow margin (1,337.16%) — 0.00%
Return on equity 923.92% — (51.96%)
Return on assets (78.91%) — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OCGN VOGX Biotechnology median
Revenue growth (TTM) (11.01%) — 6.76%
EPS growth (last fiscal year) (15.00%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric OCGN VOGX Biotechnology median
Debt to equity (0.10) 0.00 0.00
Current ratio 0.77 0.44 4.97
Net debt to EBITDA (0.17) — 1.01

Dividend

Metric OCGN VOGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OCGN VOGX Biotechnology median
Market cap 276.88m 270.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack